Novonesis (Novozymes) A/S
Research Novonesis (Novozymes) A/S (NSIS-B) on Bullrun: market cap DKK 209.94B, P/E 44.5, dividend yield 0.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNSIS-B
- ExchangeCO
- CountryDenmark
- SectorBasic Materials
- IndustrySpecialty Chemicals
- CurrencyDKK
- Market capDKK 209.94B
- P/E44.5
- Dividend yield0.9%
- Financial periodQ1 2026
- RevenueEUR 1.12B
- Net incomeEUR 199.10M
- Free cash flowEUR 74.00M
- Gross margin56.7%
Valuation Snapshot
latest market cap is DKK 209.94B; P/E is 44.5; dividend yield is 0.9%.
Peer valuation comparison
Latest P/E is 44.52x versus a Basic Materials sector median of 17.36x (156.4% above).
Latest dividend yield is 0.92% versus a Basic Materials sector median of 2.19% (58.0% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 4.16B | EUR 583.60M | EUR 811.70M | 53.9% | 1.25 | EUR 275.30M | EUR 2.92B | EUR 10.92B |
| FY2024 | EUR 3.83B | EUR 305.80M | EUR 681.60M | 47.2% | 0.67 | EUR 280.00M | EUR 1.27B | EUR 11.23B |
| FY2023 | EUR 2.40B | EUR 407.90M | EUR 308.00M | 54.3% | 1.46 | EUR 149.70M | EUR 1.49B | EUR 1.93B |
| FY2022 | EUR 17.55B | EUR 3.69B | EUR 1.25B | 54.6% | 13.19 | EUR 139.70M | EUR 3.62B | EUR 1.91B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | DKK 209.94B | 44.5 | 1.4% | 6.5 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 6.5 DKK, yield 0.9%.
| Year | Dividends/share |
|---|---|
| FY2025 | 6.45 EUR |
| FY2024 | 4 EUR |
| FY2023 | 10.2 EUR |
| FY2022 | 5.5 EUR |
About Novonesis (Novozymes) A/S
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel;
Related stock research
Other Basic Materials stocks
Frequently asked questions
What is Novonesis (Novozymes) A/S's market cap?
Novonesis (Novozymes) A/S's market capitalization is DKK 209.94B.
What is Novonesis (Novozymes) A/S's P/E ratio?
Novonesis (Novozymes) A/S's price-to-earnings (P/E) ratio is 44.5.
Does Novonesis (Novozymes) A/S pay a dividend?
Novonesis (Novozymes) A/S has a dividend yield of 0.9%.
What does Novonesis (Novozymes) A/S do?
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition.